Fardellone Patrice, Salawati Emad, Le Monnier Laure, Goëb Vincent
Department of Rheumatology, Picardie-Jules Verne University, University hospital of Amiens, 80054 Amiens, France.
Assistant Professor, Faculty of Medicine, King Abdulaziz University, 21589 Jeddah, Saudi Arabia.
J Clin Med. 2020 Oct 20;9(10):3361. doi: 10.3390/jcm9103361.
Rheumatoid arthritis (RA) is often characterized by bone loss and fragility fractures and is a frequent comorbidity. Compared with a matched population, RA patients with fractures have more common risk factors of osteoporosis and fragility fractures but also risk factors resulting from the disease itself such as duration, intensity of the inflammation and disability, and cachexia. The inflammatory reaction in the synovium results in the production of numerous cytokines (interleukin-1, interleukin-6, tumor necrosis factor) that activate osteoclasts and mediate cartilage and bone destruction of the joints, but also have a systemic effect leading to generalized bone loss. Regular bone mineral density (BMD) measurement, fracture risk assessment using tools such as the FRAX algorithm, and vertebral fracture assessment (VFA) should be performed for early detection of osteoporosis and accurate treatment in RA patients.
类风湿关节炎(RA)常以骨质流失和脆性骨折为特征,且是一种常见的合并症。与匹配的人群相比,发生骨折的RA患者有更常见的骨质疏松和脆性骨折风险因素,还有由疾病本身导致的风险因素,如病程、炎症强度和残疾程度以及恶病质。滑膜中的炎症反应会导致多种细胞因子(白细胞介素-1、白细胞介素-6、肿瘤坏死因子)的产生,这些细胞因子会激活破骨细胞并介导关节软骨和骨质破坏,还会产生导致全身性骨质流失的系统性效应。应对RA患者定期进行骨密度(BMD)测量,使用FRAX算法等工具进行骨折风险评估以及椎体骨折评估(VFA),以便早期发现骨质疏松并进行精准治疗。